Pharmaceutical Equivalence of Film-Coated and Chewable Tablets: A Comparative Dissolution Study Using Pulverized Chewable Tablets [PDF]
PharmaceuticalsFamotidine is a histamine H2 receptor antagonist used in the treatment of gastrointestinal disorders. It is available in multiple formulations, including film-coated tablets, chewable tablets, oral suspension, and injections.
Suck-Yong Park, Sung-Up Choi
doaj +4 more sources
Formulation of novel niosomal repaglinide chewable tablets using coprocessed excipients: in vitro characterization, optimization and enhanced hypoglycemic activity in rats [PDF]
Drug Delivery, 2023 Repaglinide (RPG), a monotherapy insulin secretagogue used to treat diabetes mellitus-type II yet, it suffers from poor water solubility and variable bioavailability (∼ 50%) due to hepatic first pass metabolism.
Shahinaze A. Fouad +5 more
doaj +2 more sources
Understanding the Integrity of Coating for Taste-Masked Granules – Before and After Tablet Compression [PDF]
British Journal of Pharmacy, 2018 Raman microscopy was used to visualize the integrity of a barrier membrane coating at the various stage of chewable tablets development. The effect of substrate morphology and particle characteristics was found to be important in maintaining the ...
Manish Ghimire
doaj +3 more sources
EFFECT OF VARIATION OF LUBRICANT CONCENTRATION (MAGNESIUM STEARATE) ON THE PHYSICAL QUALITY OF METOCLOPRAMID HCl TABLETS WITH DIRECT PRINTING METHOD [PDF]
Indonesian Journal of Pharmaceutical Education, 2021 Metoclopramide HCl is used to relieve nausea and vomiting. Market availability in the form of tablets, syrup and injection. The most preferred drug use by patients is oral medication because of its ease of use.
Valiandri Puspadina +4 more
doaj +3 more sources
Acceptance of oclacitinib maleate (Apoquel®) chewable tablets in client-owned dogs with allergic and atopic dermatitis [PDF]
BMC Veterinary Research, 2022 Background The oral acceptance of oclacitinib maleate (Apoquel®) chewable tablets administered twice daily for 7 days at the labeled dose range of 0.4–0.6 mg/kg was evaluated in 121 dogs treated at ten general practice veterinary clinics in the United ...
Marike Visser +4 more
doaj +2 more sources
Formulation Development of Albendazole-Loaded Self-Microemulsifying Chewable Tablets to Enhance Dissolution and Bioavailability [PDF]
Pharmaceutics, 2019 Albendazole is an anthelmintic agent with poor solubility and absorption. We developed a chewable tablet (200 mg drug equivalent), containing a self-microemulsifying drug delivery system (SMEDDS), with oral disintegrating properties.
Somchai Sawatdee +5 more
doaj +2 more sources
Investigation of the bioequivalence of montelukast chewable tablets after a single oral administration using a validated LC-MS/MS method [PDF]
Drug Design, Development and Therapy, 2015 Abdel Naser Zaid,1 Murad N Abualhasan,1 David G Watson,2 Ayman Mousa,3 Nadia Ghazal,4 Rana Bustami5 1Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine; 2Strathclyde Institute of Pharmacy and
Zaid AN +5 more
doaj +2 more sources
Chewable tablets containing rape bee pollen and maca attenuate testosterone propionate–induced benign prostatic hyperplasia in Sprague–Dawley rats by regulating the gut microbiota and modulating the IL-6/JAK2/STAT3 signaling pathway [PDF]
Frontiers in MicrobiologyBackgroundBenign prostatic hyperplasia (BPH) significantly compromises patients' quality of life, has detrimental effects on both physical and mental well-being, and poses a substantial economic burden.
Xiaoqiang Huang +11 more
doaj +2 more sources
Field efficacy of fluralaner (Bravecto® chewable tablets) for preventing Babesia canis infection transmitted by Dermacentor reticulatus ticks to dogs [PDF]
Parasites & Vectors, 2023 Background The isoxazoline fluralaner is effective for prevention of Babesia canis transmission from infected Dermacentor reticulatus ticks to dogs for 84 days in a controlled environment.
Rafael Chiummo +8 more
doaj +2 more sources
A complete cross-over design evaluating canine acceptance of Carprieve® and Rimadyl® carprofen chewable tablets in healthy dogs [PDF]
BMC Veterinary Research, 2019 Background Osteoarthritis (OA) affects nearly 20% of all dogs greater than one year of age. Clinical signs include pain, discomfort, lameness, and ultimately lead to disability.
Diana M. A. Dewsbury +3 more
doaj +2 more sources